Physician profile
John M Valosen
NPI 1447472048
$484.45
in general payments reported to CMS, 2019-2025
10 companies · $33.34 in 2025
The $33.34 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2020: $38.95 · 2021: $173 · 2022: $54.97 · 2024: $57.28 · 2025: $33.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $90.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $90.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $101.56 | 2019-2022 | |
| Stryker Corporation | $95.52 | 2019-2021 | |
| Depuy Synthes Sales INC. | $95.39 | 2019-2024 | Monovisc, Orthovisc |
| Pacira Pharmaceuticals Incorporated | $42.70 | 2020-2024 | Zilretta, Exparel, Iovera |
| Vericel Corporation | $32.42 | 2021-2022 | |
| Medacta USA, INC. | $31.74 | 2019 | |
| Curonix LLC | $30.73 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Fidia Pharma USA INC. | $19.37 | 2021 | |
| Pfizer INC. | $18.30 | 2025 | |
| Acelrx Pharmaceuticals, INC. | $16.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Valosen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.